Your browser doesn't support javascript.
loading
Development of CYP3A4 inhibition models: comparisons of machine-learning techniques and molecular descriptors.
Arimoto, Rieko; Prasad, Madhu-Ashni; Gifford, Eric M.
Afiliação
  • Arimoto R; Pfizer Global Research and Development, Ann Arbor, Michigan, USA. rieko_arimoto@vrtx.com
J Biomol Screen ; 10(3): 197-205, 2005 Apr.
Article em En | MEDLINE | ID: mdl-15809315
ABSTRACT
Computational models of cytochrome P450 3A4 inhibition were developed based on high-throughput screening data for 4470 proprietary compounds. Multiple models differentiating inhibitors (IC(50) <3 microM) and noninhibitors were generated using various machine-learning algorithms (recursive partitioning [RP], Bayesian classifier, logistic regression, k-nearest-neighbor, and support vector machine [SVM]) with structural fingerprints and topological indices. Nineteen models were evaluated by internal 10-fold cross-validation and also by an independent test set. Three most predictive models, Barnard Chemical Information (BCI)-fingerprint/SVM, MDL-keyset/SVM, and topological indices/RP, correctly classified 249, 248, and 236 compounds of 291 noninhibitors and 135, 137, and 147 compounds of 179 inhibitors in the validation set. Their overall accuracies were 82%, 82%, and 81%, respectively. Investigating applicability of the BCI/SVM model found a strong correlation between the predictive performance and the structural similarity to the training set. Using Tanimoto similarity index as a confidence measurement for the predictions, the limitation of the extrapolation was 0.7 in the case of the BCI/SVM model. Taking consensus of the 3 best models yielded a further improvement in predictive capability, kappa = 0.65 and accuracy = 83%. The consensus model could also be tuned to minimize either false positives or false negatives depending on the emphasis of the screening.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Avaliação Pré-Clínica de Medicamentos / Inibidores Enzimáticos / Inibidores das Enzimas do Citocromo P-450 / Modelos Químicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Avaliação Pré-Clínica de Medicamentos / Inibidores Enzimáticos / Inibidores das Enzimas do Citocromo P-450 / Modelos Químicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article